Immutep Limited (IMMP) is currently trading at $0.39 with a Wall Street consensus price target of $1.5, implying potential upside of 281.4% over the next 12 months. 1 analysts currently cover IMMP, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1.5, while the most cautious has a target of $1.5.
IMMP operates in the Healthcare sector with a market capitalisation of $58M. The stock is down 86.7% year-to-date and is currently trading near the lower end of its 52-week range of $0.29 – $3.53.
Other Healthcare stocks with comparable size and valuation.
Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.
Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.
StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.
View Full Rankings →